Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Pharmacy business

McKesson announces more takeover plans

McKesson Corporation (headquarters pictured) has reached an agreement to purchase the pharmaceutical distribution division of UDG Healthcare, which operates as United Drug Sangers in Northern Ireland and United Drug in Ireland

Source: Kristoffer Tripplaar / Alamy Stock Photo

McKesson Corporation has reached an agreement to purchase the pharmaceutical distribution division of UDG Healthcare

The US pharmaceutical giant behind the proposed acquisition of 281 Sainsbury’s pharmacies has announced more takeover plans for the UK and the Irish Republic.

McKesson Corporation has reached an agreement to purchase the pharmaceutical distribution division of UDG Healthcare, which operates as United Drug Sangers in Northern Ireland and United Drug in the Republic of Ireland.

The company, which has a 75% share in Celesio AG, the owner of Lloydspharmacy, also wants to acquire TCP, a homecare services provider in the Republic of Ireland, and MASTA, UDG’s UK travel healthcare business.

Celesio AG chairman Marc Owen says the latest takeover plans reflect the company’s desire to boost its growth in the European market and will complement its portfolio in the UK and the Republic of Ireland.

The proposed deal, announced on 18 September 2015, is subject to approval by UDG shareholders and will require business competition clearance from the European Union before it can go ahead.

The announcement comes just nine days after the UK’s competition watchdog revealed it was looking into the proposed acquisition by Lloydspharmacy of Sainsbury’s pharmacy business.

The Competition and Markets Authority (CMA) is investigating on the grounds that the acquisition may “reduce market competition” and is inviting comments until 23 September 2015.

McKesson says it hopes that both business acquisitions will be completed by the end of June 2016.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20069402

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • McKesson Corporation (headquarters pictured) has reached an agreement to purchase the pharmaceutical distribution division of UDG Healthcare, which operates as United Drug Sangers in Northern Ireland and United Drug in Ireland

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.